Abstract
The aim of this study was to investigate and compare changes in the nasomaxillary complex substructures following orthopaedic rapid maxillary expansion (RME) and surgically assisted RME (SARME). 10 patients received RME, 10 patients received SARME, and 10 patients served as an untreated control group. Lateral and posteroanterior cephalograms were obtained for each individual at pre-expansion/pre-control (T1) and post-expansion/post-control (T2). Descriptive parameters and transversal measurements on maxillo-mandibular dentoalveolar structures and skeletal bases, right and left nasal cavity angles (NC/Lom/VL and CN/Lom/VL, respectively), total nasal cavity angle (NC/Lom/CN), nasal cavity width (NC-CN) and nasal septum angle (sn/Lom/VL) were also calculated. Paired t -tests were used to evaluate changes within groups following treatment/control. Analysis of variance (ANOVA) and Duncan’s tests were used to compare changes between groups. With the exception of nasal septum deviation, all nasal parameters significantly increased following RME and SARME. The increases in the SARME group were greater than in the other groups, but no statistically significant differences were recorded between the RME and SARME groups. Neither RME nor SARME created positional changes in the nasal septum.
Rapid maxillary expansion (RME) has been the gold standard for maxillary expansion in children and adolescents. Surgically assisted rapid maxillary expansion (SARME), which involves surgical weakening of certain anatomic structures of the midface prior to RME, has been proposed as a means of obtaining better results in adults and avoiding bone fracture, pain and gingival complications .
RME and SARME have been successful in the treatment of maxillary transverse deficiency, nasal airway resistance , nasal septum deviation and obstructive sleep apnea . Patients presenting with maxillary transverse deficiency have also been reported to have small nasal cross-sectional areas . It has been suggested that by gradually increasing nasal volume and reducing nasal airway resistance , maxillary expanders lead to improved breathing, physical development, athletic performance and general health .
No differences have been reported between RME and SARME with the exception of indication , which is based on the facial skeleton’s increased resistance to maxillary expansion that occurs with age and skeletal maturation. It is possible that SARME could be more effective than RME in increasing nasal dimensions because it offers more parallel expanded maxillary bony segments. The objective of the present study was to determine if there is a difference between the effects of orthopaedic RME and SARME on nasal structures.
Materials and methods
Subjects
This study examined lateral cephalometric radiographs from 30 subjects ( Table 1 ). 20 subjects were patients at the Ankara University, Faculty of Dentistry, and 10 subjects were randomly selected from the Faculty’s longitudinal archives as controls. Inclusion criteria for the maxillary expansion groups were: presence of posterior bilateral cross-bite with skeletal involvement; no future orthognathic surgery required; and no pre-expansion orthodontics applied.
Groups | N | Chronological age (years) | ||||
---|---|---|---|---|---|---|
X | Sx | Min | Max | |||
SARME | 10 | ♀: 7 | 19.01 | 1.22 | 16.25 | 25.58 |
♂: 3 | ||||||
RME | 10 | ♀: 6 | 15.51 | 1.09 | 13.33 | 17.58 |
♂: 4 | ||||||
Control | 10 | ♀: 6 | 15.27 | 1.43 | 13.42 | 17.00 |
♂: 4 |
The RME group comprised 10 patients (six male, four female) with a mean age of 15.51 years (range 13.33–17.58 years) and a minimum skeletal age of 15 years, according to Greulich–Pyle hand–wrist analysis . The SARME group comprised 10 patients (seven male, three female) with a mean age of 19.01 years (range 16.25–25.58 years) and a minimum skeletal age of 17 years, according to Greulich–Pyle hand–wrist analysis . Of the 10 patients in the SARME group, six patients were older than 17 years and four patients were 17 years or younger. The latter four patients were initially treated by RME, but their treatment was continued with surgical assistance due to discomfort, pain and resistance to expansion. Patients in the RME group had completed 99.2% (minimum: 98.6%, maximum: 99.8%) of their growth potential, and the patients in the SARME group had completed 99.5% (minimum: 99.1%, maximum: 100%) of their growth potential . The control group comprised 10 untreated subjects (six male, four female) matched to the RME group for sex and age ( Table 1 ) in order to assess the effects of nasopharyngeal growth over a 1-year follow-up period. (Growth of the airway is complete at approximately 15 years of age , so controls were not required for the SARME group.) The same type of expansion appliance and surgical procedure was used in all cases ( Fig. 1 ).
SARME
Subjects in this group received occlusal-coverage Hyrax-type palatal expanders. Surgery was performed under local anaesthesia. Bilateral incisions were made at the depth of the vestibule from the first molar area to the distal aspect of the lateral incisor. The mucoperiosteum was elevated, and the maxillary bone exposed from the piriform aperture to the pterygomaxillary fissure. After identifying the infraorbital nerve, an osteotomy was performed horizontally from the piriform aperture to the pterygomaxillary fissure well above the apices of the teeth. The pterygoid plates were not separated from the maxilla. An additional vertical incision was made parallel to the labial frenulum, and the maxilla was separated by malleting a thin osteotome between the central incisors at a level below the anterior nasal spine. The surgical sites were irrigated and sutured. An anterior nasal package and pressure bandage was applied to patients for 24 h, and antibiotics, analgesics and oroantral regime were prescribed.
Screws were activated immediately after bonding in the RME group and after surgery in the SARME group. For both groups, activation consisted of two turns per day and was performed for 2–3 weeks until the necessary amount of expansion was achieved. Upon completion of expansion, appliances were left in place for 12 weeks. At the end of the 12-week post-expansion period (T2), the appliances were removed and replaced by transpalatal arches for the remainder of the conventional orthodontic treatment period.
Cephalometric evaluation
Pre-expansion/pre-control (T1) and post-expansion/post-control (T2) posteroanterior and lateral cephalograms were taken from all subjects. Occlusal radiographs were also obtained from patients in the RME and SARME groups.
Posteroanterior and lateral cephalograms were traced, and cephalometric reference points were identified using a 0.3 mm lead pencil on 0.003-in. frosted acetate tracing paper. Craniofacial ( Fig. 2 ) and nasal ( Figs 3 and 4 ) measurements were made on all cephalograms using the PorDios cephalometric analysis program (Purpose on Request Digitizer Input Output System, Institute of Orthodontic Computer Science, Aarhus, Denmark). The linear and angular measurements of nasal structures presented in Figs 3 and 4 were previously reported in studies by Altug-Atac et al. and Kyrkanides et al. .
Statistical analysis
Mean values and standard errors were examined to compare linear changes both within and between groups. Analysis of variance (ANOVA) and Duncan’s tests were used to make comparisons between groups at T1 ( Table 2 ) and within groups between T1 and T2 ( Table 3 ). Paired t -tests were also used to analyze changes between T1 and T2 within each group ( Table 3 ).
Parameters | SARME | RME | Control | Test | SARME vs. RME | RME vs. control | SARME vs. control | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
X | ±Sx | X | ±Sx | X | ±Sx | ||||||
Lateral cephalometric measurements | |||||||||||
Maxilla | |||||||||||
1. SNA | deg | 75.28 | 0.94 | 74.57 | 0.96 | 80.77 | 3.32 | * | * | * | |
Mandible | |||||||||||
2. SNB | deg | 75.20 | 1.32 | 77.56 | 1.07 | 77.97 | 2.36 | ||||
Maxillo-mandibular relations | |||||||||||
3. ANB | deg | 0.08 | 0.67 | −2.98 | 1.30 | 2.80 | 1.94 | ** | ** | ** | ** |
4. SN/GoGn | deg | 42.80 | 1.32 | 41.90 | 1.08 | 31.46 | 3.58 | *** | *** | *** | |
5. Overjet | mm | 1.92 | 0.82 | −1.82 | 1.67 | 3.01 | 1.64 | ** | ** | ** | |
6. Overbite | mm | −1.61 | 1.48 | 1.15 | 0.52 | 1.85 | 1.98 | ** | ** | ** | |
Posteroanterior radiographic measurements | |||||||||||
Maxillary skeletal and dentoalveolar measurements | |||||||||||
7. MxR-MxL | mm | 66.79 | 2.16 | 62.80 | 0.56 | 71.18 | 0.17 | ** | ** | * | |
8. ApR-ApL | mm | 7.79 | 0.33 | 6.76 | 0.44 | 7.03 | 0.47 | ||||
9. UmolR-UmolL | mm | 54.88 | 2.38 | 55.04 | 0.93 | 60.19 | 0.71 | * | * | * | |
10. MxR/cg/MxL | deg | 50.61 | 1.24 | 48.93 | 1.41 | 53.27 | 1.02 | * | * | ||
11.UmolR/cg/UmolL | deg | 34.13 | 1.50 | 36.30 | 0.80 | 39.41 | 2.11 | * | * | ||
Measurements of nasal structures | |||||||||||
12. NC-Lom-VML | deg | 16.91 | 0.65 | 18.20 | 0.56 | 17.75 | 0.82 | ||||
13. CN-Lom-VML | deg | 19.27 | 0.51 | 19.15 | 0.94 | 17.60 | 0.82 | ||||
14. NC-Lom-CN | deg | 36.18 | 0.81 | 37.35 | 1.46 | 35.35 | 1.07 | ||||
15. NC-CN | mm | 32.15 | 1.02 | 31.75 | 0.83 | 32.01 | 0.74 | ||||
16. sn-Lom-VML | deg | 0.93 | 1.53 | 1.05 | 0.91 | 0.78 | 1.23 | ||||